co.don AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,684.30
2,493.30
2,865.80
3,650.50
7,054.30
6,271
Depreciation, Depletion & Amortization
186.80
214.30
249.40
241.00
246.90
715
Other Funds
-
-
-
-
78.50
3,407
Funds from Operations
2,804.00
2,135.00
3,285.40
3,362.50
5,813.00
7,688
Changes in Working Capital
1,239.60
357.30
311.60
253.90
139.90
450
Net Operating Cash Flow
1,564.30
1,777.70
2,973.90
3,616.40
5,952.90
8,138
Capital Expenditures
560.70
124.00
1,307.70
169.40
3,961.80
Sale of Fixed Assets & Businesses
-
-
-
-
0.70
Net Investing Cash Flow
560.70
124.00
1,307.70
169.40
3,961.00
Net Financing Cash Flow
490.30
4,966.20
5,752.70
24.30
20,556.60
Net Change in Cash
1,634.80
3,064.50
1,471.20
3,761.60
10,642.70
Free Cash Flow
1,967.60
1,891.60
4,281.60
3,768.30
9,906.10
Change in Capital Stock
490.30
4,966.20
5,752.70
24.30
20,478.10

About co.don

View Profile
Address
Warthestrasse 21
Teltow Brandenburg 14513
Germany
Employees -
Website http://www.codon.de
Updated 07/08/2019
co. don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. Its customers include accident surgeons, orthopaedic surgeons, and neurosurgeons in clinics and specialised practices.